Of our country the intersection of hepatitis B and the intersection of immunity and therapeutic vaccine study and make progress
Of our country the intersection of hepatitis B and the intersection of immunity and therapeutic vaccine study and make progress
Wuhan, March 16 (Xinhua) reporter Liu JiaJing learns from the third China and Japan scientific forum that holds in Wuhan on the 16th, Chinese the intersection of hepatitis B and the intersection of immunity and therapeutic vaccine study and make progress, it is estimated that three clinical test results appear at the end of this year, but the distance produces and needs time finally. The third China and Japan scientific forum is undertaken by the virus of Wuhan of Chinese Academy of Sciences. Academician of Chinese Academy of Engineering, chief pathogenic microbe of Fudan University smell the jade plum introduction, therapeutic vaccine of immunity of hepatitis B is replied through regulating the human immunity, treat a kind of unique products of hepatitis B and virus. Use medicine different passively with patient, the vaccine can shift human body carry on initiative immunity, have therapeutic effects to the early hepatitis B patient without liver cirrhosis, in addition it is small and at one time treating the low grade characteristic of the expenses to have a side effect. It is reported hepatitis B the intersection of immunity and therapeutic the intersection of vaccine and research project belong to the intersection of country and " the 863 " One of the plans, has already launched for 22 years so far. YuMei Wen say immunity the intersection of treatment and vaccine it develops to be must strictly according to clinical test procedure that new medicine researched and developed, this vaccine, already through the first stage of, the second stage of clinical trial, ongoing three clinical trials purpose lies in further proving curative effect, stability at present, explore that is able to bear nature, side effect,etc..
|
No comments:
Post a Comment